Sun. November 22, 2009
-
123Jump.com
November 21, 2009
Ranbaxy Laboratories Limited rose 0.7% to Rs 420.45 after the
pharmaceutical industry said on
friday that it has voluntarily recalled one lot of Sotret ...
India Infoline.com
November 20, 2009
Ranbaxy Laboratories reported net profit of Rs 186.08 crore in Q3 September 2009 as compared to net loss of Rs 352.93 crore in Q3 September 2008. ...
Economic Times
November 19, 2009
As many as 19 companies saw their brand values decline, with the highest fall of 56 per cent being seen in
Jet Airways, followed by
Ranbaxy Laboratories ...
Economic Times
November 19, 2009
10:15 am: Top 10 Nifty gainers were Suzlon Energy (2.18%),
Ranbaxy Laboratories (2.10%), Reliance Power (1.98%), Reliance Capital, Jindal
steel, Hero Honda, ...
Economic Times
November 19, 2009
Suzlon (3.82%),
Ranbaxy Laboratories (1.75%), Reliance Power (1.25%), Jindal
steel (1.12%), Power Grid (0.81%) were amongst the top Nifty gainers. ...
RTT News
November 19, 2009
Clopidogrel is presently marketed as Plavix by
Sanofi-Aventis (SNY: News ), as Clopilet by Sun Pharmaceuticals, as Ceruvin by
Ranbaxy Laboratories, ...
Moneycontrol.com
November 19, 2009
Buy Ranbaxy Laboratories with a target of Rs 460 per share and stop loss at Rs 410 per share. Ranbaxy has been in a roll after that big decline. ...
Sify
November 18, 2009
Orchid Chemicals, Piramal
healthcare, Glenmark Pharmaceuticals, IPCA Laboratories, Cipla,
Ranbaxy Laboratories, Biocon and Dishman Pharma are among the ...
Reuters India
November 17, 2009
It would be five years before they stand in our way," Sawai President Mitsuo Sawai told Reuters in an interview, referring to Ranbaxy Laboratories (RANB. ...
Moneycontrol.com
November 17, 2009
Cipla we have a target of Rs 320, Ranbaxy Laboratories could move to levels like Rs 440, Bajaj Hindusthan is something which could move to Rs 238. ...
Business Standard
November 15, 2009
The key strategic investments made by the erstwhile promoters of Ranbaxy Laboratories may seem to be floundering on the surface, but the Daiichi-owned ...
India Infoline.com
November 12, 2009
In September 2009,
Ranbaxy Laboratories entered into a strategic in-licensing agreement with Medy-Tox Inc of
South Korea, for selling a cosmetic product in ...
Trading Markets (press release)
November 12, 2009
... Inc., has entered into an exclusive license agreement with
Ranbaxy Laboratories Limited, for the supply and distribution of Oxoferin(TM) in
Malaysia, ...
Reuters
November 12, 2009
New Delhi (Dow Jones)--
Ranbaxy Laboratories Ltd. (500359.BY) will take "a long time" to resolve issues with
the US Food and Drug ...
SUZLON Energy (6.56%), JP Associates (5.37%),
Ranbaxy Laboratories (4.17%), IDFC (3.91%) and Tata
steel (3.04%) were the top Nifty gainers. ...
Economic Times
November 4, 2009
Trading Markets (press release)
November 3, 2009
Nov 03, 2009 (Datamonitor Financial Deals Tracker via COMTEX) -- RBXLF | Quote | Chart | News | powerrating -- Ranbaxy Laboratories
Trading Markets (press release)
November 3, 2009
New Delhi, Sep 03, 2009 (
Asia Pulse Data Source via COMTEX) -- RBXLF | Quote | Chart | News | powerrating --
Ranbaxy Laboratories
FiercePharma
November 2, 2009
Report > Ranbaxy Laboratories
Rediff
November 1, 2009
It all started when Daiichi Sankyo of Japan [ Images ] acquired Ranbaxy Laboratories
Economic Times
November 1, 2009
Myiris.com
October 31, 2009
Credit rating agency, CARE has retained the PR1+ rating assigned to the Short-term Bank Facilities aggregating Rs 9000 million of Ranbaxy (Q,N,C,F)* ...
Reuters India
October 30, 2009
Mumbai (Reuters) -
Ranbaxy Laboratories
Reuters
October 29, 2009
Daiichi, which owns a majority of
India's
Ranbaxy Laboratories
Business Standard
October 28, 2009
PTI /
New Delhi October 28, 2009, 19:19 IST
Ranbaxy Laboratories
Oct. 26 (Bloomberg) --
Ranbaxy Laboratories Ltd.,
India's biggest drugmaker, posted a third-quarter profit that beat
analysts' ...
Myiris.com
October 26, 2009
Ranbaxy Laboratories
Patent Docs (blog)
October 26, 2009
Defendants: Ranbaxy Inc.; Ranbaxy Pharmaceuticals Inc.; Ranbaxy Laboratories Ltd. Infringement of US Patent No. 5508042 ("Controlled Release Oxycodone ...
Reuters India
October 26, 2009
In recent times,
the US regulator has faulted the manufacturing procedures of several drug firms including
Ranbaxy Laboratories and a unit of Sun ...
Economic Times
October 26, 2009
11:09 am: Ranbaxy Laboratories Ltd has reported standalone net profit of Rs. 186.08 crore for the quarter ended Sep 30, 2009 against a loss of Rs. 352.93 ...
Reuters
October 26, 2009
Ranbaxy Laboratories (RANB.BO) closed 2.6 percent higher at 381.90 rupees after the top drugmaker reported a standalone net profit of 1.86 billion rupees ...
Alibaba News Channel
October 26, 2009
global demand for generic drugs from drugmakers such as Dr Reddy's and domestic rivals
Ranbaxy Laboratories and Cipla Ltd is booming as nations battle ...
Sify
October 26, 2009
Select pharma stocks, led by
Ranbaxy Laboratories, are moving higher on firm buying support.
information technology and FMCG stocks are also seen trading ...
Hindu Business Line
October 26, 2009
Mumbai:
Ranbaxy Laboratories Ltd has posted a net profit after
tax of Rs 186.08 crore for the third quarter ended September 30, 2009 compared with a net ...
FiercePharma
October 26, 2009
Report >
Ranbaxy Laboratories,
India's biggest drugmaker, posted a third-quarter profit that beat
analysts' estimates on lower costs and a smaller foreign- ...
123Jump.com
October 26, 2009
Ranbaxy Laboratories Limited sales fell 8.9% and net profit fell 70.4%. Maruti Suzuki
India Limited, the passenger carmaker said second quarter sales rose ...
Business Standard
October 26, 2009
India's biggest drug maker,
Ranbaxy Laboratories, has posted a net profit of Rs 116.6 crore for its third quarter ended September, against a net loss of Rs ...
Business Standard
October 24, 2009
For instance, Ranbaxy Laboratories' takeover by Daiichi Sankyo. Sometimes, a takeover offers a good opportunity to exit the stock during the open offer. ...
路透中国
October 23, 2009
global demand for generic drugs from companies such as Dr Reddy's and domestic rivals
Ranbaxy Laboratories (RANB.BO: è¡ÂæÂ...) and Cipla Ltd (CIPL. ...
